Tesamorelin is an analog of growth hormone-releasing hormone (GHRH) that is clinically used for the treatment of lipodystrophy (dysfunctional fat deposition) associated with HIV. It is also being researched for its potential to improve peripheral nerve health, slow the progression of mild cognitive decline, and reduce fat mass.
What is Tesamorelin?
Tesamorelin is a synthetic peptide used in medicine for a specific purpose. It is classified as an analog of growth hormone-releasing hormone (GHRH) and is primarily used to stimulate the production and release of growth hormone (GH) from the pituitary gland. This hormone is crucial in various physiological processes, including growth, metabolism, and tissue repair.
This peptide is commonly prescribed to individuals with HIV-associated lipodystrophy. It helps reduce excess abdominal fat, improving body composition and potentially enhancing insulin sensitivity.
Tesamorelin | Peptide
Freedom Research
Tesamorelin is typically administered via subcutaneous injection. The usual dosage is 2 mg once daily, injected into the fatty tissue of the abdomen. It is important to follow the prescribed treatment plan and consult a healthcare provider for guidance. Regular monitoring of fat reduction and insulin sensitivity may be recommended.